Stocks
Funds
Screener
Sectors
Watchlists
EXPO

EXPO - Exponent Inc Stock Price, Fair Value and News

$67.41-2.27 (-3.26%)
Delayed

41/100

EXPO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

41/100

EXPO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

EXPO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EXPO Price Action

Last 7 days

-6.2%

Last 30 days

-6.0%

Last 90 days

-8.5%

Trailing 12 Months

-17.6%

EXPO RSI Chart

EXPO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EXPO Valuation

Market Cap

3.3B

Price/Earnings (Trailing)

31.32

Price/Sales (Trailing)

5.7

EV/EBITDA

19.69

Price/Free Cashflow

27.14

EXPO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

EXPO Fundamentals

EXPO Revenue

Revenue (TTM)

582.0M

Rev. Growth (Yr)

7.79%

Rev. Growth (Qtr)

0.21%

EXPO Earnings

Earnings (TTM)

106.0M

Earnings Growth (Yr)

4.97%

Earnings Growth (Qtr)

-11.7%

EXPO Profitability

EBT Margin

25.31%

Return on Equity

27.16%

Return on Assets

13.63%

Free Cashflow Yield

3.68%

EXPO Investor Care

Dividend Yield

1.78%

Dividend/Share (TTM)

1.2

Buy Backs (1Y)

3.08%

Diluted EPS (TTM)

2.08

EXPO Alerts

  • 1 major insider buys and 2 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025559.1M560.5M571.4M582.0M
2024541.4M541.7M544.6M558.5M
2023525.1M535.1M541.2M536.8M
2022478.3M488.7M499.4M513.3M
2021410.4M438.3M456.0M466.3M
2020424.1M409.7M406.8M399.9M
2019382.1M393.0M399.2M417.2M
2018360.1M367.9M375.7M379.5M
2017316.0M326.6M336.5M347.8M
2016315.7M313.1M311.7M315.1M
2015309.0M312.3M312.8M312.8M
2014299.5M300.5M303.9M304.7M
2013293.4M294.4M296.3M296.2M
2012270.9M280.3M287.6M292.7M
2011262.8M267.5M267.1M272.4M
EXPO
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
 CEO
 WEBSITEexponent.com
 SECTORIndustrials
 INDUSTRYEngineering & Construction
 EMPLOYEES1077

Exponent Inc Frequently Asked Questions


EXPO is the stock ticker symbol of Exponent Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Exponent Inc is 3.32 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, EXPO's PE ratio (Price to Earnings) is 31.32 and Price to Sales (PS) ratio is 5.7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EXPO PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Exponent Inc has provided 0.107 (multiply by 100 for percentage) rate of return.